Companies Cryptocurrencies
Harpoon Therapeutics Inc
Harpoon Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 08/02/2019
CEO: Dr. Gerald McMahon
Biotechnology Healthcare 🔗
  • HARP
    symbol
  • 19.29
    price
  • 621589440
    market cap
  • 0.98
    changes
If you bought

shares of Harpoon Therapeutics Inc (HARP) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which develops a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The company is headquartered in South San Francisco, California and currently employs 55 full-time employees. The firm is engaged in a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct, or TriTAC, platform, the Company is developing a pipeline of T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Its TriTAC product candidate, HPN424, is focused on the treatment of metastatic castration-resistant prostate cancer, or mCRPC.

Address: 131 Oyster Point Blvd Ste 300 South San Francisco CALIFORNIA 94080

Stay updated.